{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:22:06Z","timestamp":1787908926298,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical Research Project of The People\u2019s Hospital of Yubei District of Chongqing City","award":["ybyk2023-10"],"award-info":[{"award-number":["ybyk2023-10"]}]},{"name":"Joint Medical Research Project of Science and Health in Yubei District, Chongqing City","award":["2023YBKW16"],"award-info":[{"award-number":["2023YBKW16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05601-2","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:46:03Z","timestamp":1781858763000},"page":"3419-3437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["COLEC12 promotes pancreatic cancer progression via the activation of the TGF-\u03b2 signaling pathway"],"prefix":"10.1007","volume":"481","author":[{"given":"Xin","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"10485","key":"5601_CR1","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop TF, Javed AA, Oba A, Koerkamp BG, Seufferlein T, Wilmink JW, Besselink MG (2025) Pancreatic cancer. Lancet 405(10485):1182\u20131202. https:\/\/doi.org\/10.1016\/S0140-6736(25)00261-2","journal-title":"Lancet"},{"issue":"1","key":"5601_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02421-z","volume":"11","author":"X Liang","year":"2025","unstructured":"Liang X, Tian R, Li T, Wang H, Qin Y, Qian M, Fan J, Wang D, Cui HY, Jiang J (2025) Integrative insights into the role of CAV1 in ketogenic diet and ferroptosis in pancreatic cancer. Cell Death Discov 11(1):139. https:\/\/doi.org\/10.1038\/s41420-025-02421-z","journal-title":"Cell Death Discov"},{"issue":"1","key":"5601_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02603-9","volume":"11","author":"X Ma","year":"2025","unstructured":"Ma X, Cheng M, Jia Y, Zhang K, Zhang H, Feng D, Xu W, Qiao G (2025) Demethylzeylasteral suppresses the expression of MESP1 by reducing H3K18la level to inhibit the malignant behaviors of pancreatic cancer. Cell Death Discov 11(1):305. https:\/\/doi.org\/10.1038\/s41420-025-02603-9","journal-title":"Cell Death Discov"},{"issue":"1","key":"5601_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07164-0","volume":"23","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Cao Z, Yan S, Chen B, Wu H, Cao H, Lin C, Liu Z (2025) Metabolic and immune crosstalk between cancer-associated fibroblasts and pancreatic cancer cells. J Transl Med 23(1):1118. https:\/\/doi.org\/10.1186\/s12967-025-07164-0","journal-title":"J Transl Med"},{"issue":"1","key":"5601_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02674-8","volume":"11","author":"YN Hwang","year":"2025","unstructured":"Hwang YN, Park JH, Na HH, Kwon TH, Park JS, Chae S, Oh YT, Kim KC (2025) Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy. Cell Death Discov 11(1):377. https:\/\/doi.org\/10.1038\/s41420-025-02674-8","journal-title":"Cell Death Discov"},{"issue":"1","key":"5601_CR6","doi-asserted-by":"publisher","first-page":"101696","DOI":"10.1016\/j.gendis.2025.101696","volume":"13","author":"Z Cai","year":"2025","unstructured":"Cai Z, Liu M, Wang W, Yao H, Yang S, Li C, Hu X, Pu Y, Ma J, Jiang C (2025) LINC00431 modulates KRAS and p53 stability to drive pancreatic cancer progression under hypoxia. Genes Dis 13(1):101696 PMID: 41019510; PMCID: PMC12466122","journal-title":"Genes Dis"},{"issue":"5","key":"5601_CR7","doi-asserted-by":"publisher","first-page":"101490","DOI":"10.1016\/j.gendis.2024.101490","volume":"12","author":"J Zhang","year":"2024","unstructured":"Zhang J, Gu J, Zhang T, Xia R, Li J, Tan M, Yang Y, Xiang J, Xie B, Tang R, Li W, Wang X, Guo S, Wang H (2024) The role of the aging process and related factor EMP1 in promoting progression of resectable pancreatic cancer. Genes Dis 12(5):101490. https:\/\/doi.org\/10.1016\/j.gendis.2024.101490","journal-title":"Genes Dis"},{"issue":"1","key":"5601_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02922-x","volume":"12","author":"K Ye","year":"2025","unstructured":"Ye K, Zhou S, Gong X, Zhu Z, Xiao M, Liang S (2025) TGM2-P2RX7 loop promotes gemcitabine resistance in pancreatic cancer by modulating glutamine metabolism and mitophagy. Cell Death Discov 12(1):2. https:\/\/doi.org\/10.1038\/s41420-025-02922-x","journal-title":"Cell Death Discov"},{"issue":"1","key":"5601_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02382-3","volume":"11","author":"M Masi","year":"2025","unstructured":"Masi M, Poppi L, Previtali V, Nelson SR, Wynne K, Varignani G, Falchi F, Veronesi M, Albanesi E, Tedesco D, De Franco F, Ciamarone A, Myers SH, Ortega JA, Bagnolini G, Ferrandi G, Farabegoli F, Tirelli N, Di Stefano G, Oliviero G, Walsh N, Roberti M, Girotto S, Cavalli A (2025) Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity. Cell Death Discov 11(1):106. https:\/\/doi.org\/10.1038\/s41420-025-02382-3","journal-title":"Cell Death Discov"},{"issue":"1","key":"5601_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41420-025-02321-2","volume":"11","author":"C Duranti","year":"2025","unstructured":"Duranti C, Iorio J, Manganelli V, Bagni G, Colasurdo R, Lottini T, Martinelli M, Capitani C, Boso G, D\u2019Alessandro FN, Sorice M, Becchetti A, Misasi R, Garofalo T, Arcangeli A (2025) Targeting the hERG1\/\u03b21 integrin complex in lipid rafts potentiates statins anti-cancer activity in pancreatic cancer. Cell Death Discov 11(1):39. https:\/\/doi.org\/10.1038\/s41420-025-02321-2","journal-title":"Cell Death Discov"},{"issue":"1","key":"5601_CR11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1186\/s12967-025-06711-z","volume":"23","author":"J Ge","year":"2025","unstructured":"Ge J, Cai J, Zhang G, Li D, Tao L (2025) Multi-omics integration and machine learning uncover molecular basal-like subtype of pancreatic cancer and implicate A2ML1 in promoting tumor epithelial-mesenchymal transition. J Transl Med 23(1):741. https:\/\/doi.org\/10.1186\/s12967-025-06711-z","journal-title":"J Transl Med"},{"issue":"5","key":"5601_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ccell.2019.09.002","volume":"36","author":"ZA Qadeer","year":"2019","unstructured":"Qadeer ZA, Valle-Garcia D, Hasson D et al (2019) ATRX in-frame fusion neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal gene signatures. Cancer Cell 36(5):512-527e9. https:\/\/doi.org\/10.1016\/j.ccell.2019.09.002","journal-title":"Cancer Cell"},{"issue":"1","key":"5601_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13046-021-01948-0","volume":"40","author":"L Li","year":"2021","unstructured":"Li L, Gong Y, Xu K et al (2021) ZBTB28 induces autophagy by regulation of FIP200 and Bcl-XL facilitating cervical cancer cell apoptosis. J Exp Clin Cancer Res 40(1):150. https:\/\/doi.org\/10.1186\/s13046-021-01948-0","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"5601_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3892\/ijo.2022.5312","volume":"60","author":"M Abdulla","year":"2022","unstructured":"Abdulla M, Traiki TB, Vaali-Mohammed MA et al (2022) Targeting MUCL1 protein inhibits cell proliferation and EMT by deregulating \u03b2-catenin and increases irinotecan sensitivity in colorectal cancer. Int J Oncol 60(3):22. https:\/\/doi.org\/10.3892\/ijo.2022.5312","journal-title":"Int J Oncol"},{"issue":"1","key":"5601_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13148-018-0459-2","volume":"10","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Fan J, Fan Y et al (2018) The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via \u03b2-catenin\/Cdc25c signaling and G2\/M arrest. Clin Epigenetics 10(1):26. https:\/\/doi.org\/10.1186\/s13148-018-0459-2","journal-title":"Clin Epigenetics"},{"issue":"1","key":"5601_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics. CA Cancer J Clin 74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"5601_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41568-021-00418-1","volume":"22","author":"AA Connor","year":"2022","unstructured":"Connor AA, Gallinger S (2022) Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Nat Rev Cancer 22(3):131\u2013142. https:\/\/doi.org\/10.1038\/s41568-021-00418-1","journal-title":"Nat Rev Cancer"},{"issue":"47","key":"5601_CR18","doi-asserted-by":"publisher","first-page":"44222","DOI":"10.1074\/jbc.M103942200","volume":"276","author":"K Ohtani","year":"2001","unstructured":"Ohtani K, Suzuki Y, Eda S et al (2001) The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J Biol Chem 276(47):44222\u201344228. https:\/\/doi.org\/10.1074\/jbc.M103942200","journal-title":"J Biol Chem"},{"issue":"7","key":"5601_CR19","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.4049\/jimmunol.1500493","volume":"195","author":"YJ Ma","year":"2015","unstructured":"Ma YJ, Hein E, Munthe-Fog L et al (2015) Soluble collectin-12 (CL-12) is a pattern recognition molecule initiating complement activation via the alternative pathway. J Immunol 195(7):3365\u20133373. https:\/\/doi.org\/10.4049\/jimmunol.1500493","journal-title":"J Immunol"},{"issue":"6","key":"5601_CR20","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1074\/jbc.M807477200","volume":"284","author":"S Jang","year":"2009","unstructured":"Jang S, Ohtani K, Fukuoh A et al (2009) Scavenger receptor collectin placenta 1 (CL-P1) predominantly mediates zymosan phagocytosis by human vascular endothelial cells. J Biol Chem 284(6):3956\u20133965. https:\/\/doi.org\/10.1074\/jbc.M807477200","journal-title":"J Biol Chem"},{"key":"5601_CR21","doi-asserted-by":"publisher","first-page":"153303382312181","DOI":"10.1177\/15330338231218163","volume":"22","author":"X Sun","year":"2023","unstructured":"Sun X, Zhang Q, Shu P, Lin X, Gao X, Shen K (2023) COLEC12 promotes tumor progression and is correlated with poor prognosis in gastric cancer. Technol Cancer Res Treat 22:15330338231218164. https:\/\/doi.org\/10.1177\/15330338231218163","journal-title":"Technol Cancer Res Treat"},{"issue":"11","key":"5601_CR22","doi-asserted-by":"publisher","first-page":"e23469","DOI":"10.1002\/jcla.23469","volume":"34","author":"GZ Li","year":"2020","unstructured":"Li GZ, Deng JF, Qi YZ, Liu R, Liu ZX (2020) COLEC12 regulates apoptosis of osteosarcoma through Toll-like receptor 4-activated inflammation. J Clin Lab Anal 34(11):e23469. https:\/\/doi.org\/10.1002\/jcla.23469","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"5601_CR23","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/biomedicines13051203","volume":"13","author":"J Zhang","year":"2025","unstructured":"Zhang J, Jiang Z, Jin J, Kadeerhan G, Guo H, Wang D (2025) Investigating the genetic links between immune cell profiles and bladder cancer: a multidisciplinary bioinformatics approach. Biomedicines 13(5):1203. https:\/\/doi.org\/10.3390\/biomedicines13051203","journal-title":"Biomedicines"},{"key":"5601_CR24","doi-asserted-by":"publisher","first-page":"1157861","DOI":"10.3389\/fonc.2023.1157861","volume":"13","author":"X Zhang","year":"2023","unstructured":"Zhang X, Sun Y, Ma Y et al (2023) Tumor-associated M2 macrophages in the immune microenvironment influence the progression of renal clear cell carcinoma by regulating M2 macrophage-associated genes. Front Oncol 13:1157861. https:\/\/doi.org\/10.3389\/fonc.2023.1157861","journal-title":"Front Oncol"},{"issue":"1","key":"5601_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP (2016) EMT: 2016. Cell 166(1):21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028","journal-title":"Cell"},{"issue":"20","key":"5601_CR26","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.3390\/ijms21207624","volume":"21","author":"I Kaszak","year":"2020","unstructured":"Kaszak I, Witkowska-Pi\u0142aszewicz O, Niewiadomska Z, Dworecka-Kaszak B, Ngosa Toka F, Jurka P (2020) Role of Cadherins in cancer-a review. Int J Mol Sci 21(20):7624. https:\/\/doi.org\/10.3390\/ijms21207624","journal-title":"Int J Mol Sci"},{"key":"5601_CR27","doi-asserted-by":"publisher","first-page":"646399","DOI":"10.3389\/fonc.2021.646399","volume":"11","author":"T Luu","year":"2021","unstructured":"Luu T (2021) Epithelial-mesenchymal transition and its regulation mechanisms in pancreatic cancer. Front Oncol 11:646399. https:\/\/doi.org\/10.3389\/fonc.2021.646399","journal-title":"Front Oncol"},{"issue":"1","key":"5601_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"DM Xu","year":"2025","unstructured":"Xu DM, Chen LX, Xue T, Zhuang XY, Wei LC, Han H, Mo M (2025) Decoding the impact of MMP1\u2009+\u2009malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics. Cell Death Discov 11(1):244. https:\/\/doi.org\/10.1038\/s41420-025-02503-y","journal-title":"Cell Death Discov"},{"issue":"1","key":"5601_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12967-025-06596-y","volume":"23","author":"Q Wang","year":"2025","unstructured":"Wang Q, Feng W, Tan Y, Qiao J, Liu H, Liu Q, Wang H, Zhang Q, Tao J, Li Z, Yang B, Xu Z, Wang C, Yang S, Cui L (2025) Antiphospholipid antibodies inhibit the migration and invasion of trophoblast cells by suppressing the JNK\/C-Jun\/MMP1 signaling pathway. J Transl Med 23(1):581. https:\/\/doi.org\/10.1186\/s12967-025-06596-y","journal-title":"J Transl Med"},{"issue":"5","key":"5601_CR30","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.gendis.2025.101529","volume":"12","author":"S Tian","year":"2025","unstructured":"Tian S, Chen X, Li J (2025) Zinc finger transcription factor ZNF24 inhibits colorectal cancer growth and metastasis by suppressing MMP2 transcription. Genes Dis 12(5):101529. https:\/\/doi.org\/10.1016\/j.gendis.2025.101529","journal-title":"Genes Dis"},{"issue":"1","key":"5601_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41420-025-02536-3","volume":"11","author":"Z Wang","year":"2025","unstructured":"Wang Z, Sun H, Zhu S, Wang F, Li Q, Zhou J (2025) RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-\u03b2 signaling pathway and promoting EMT in ovarian cancer. Cell Death Discov 11(1):262. https:\/\/doi.org\/10.1038\/s41420-025-02536-3","journal-title":"Cell Death Discov"},{"issue":"1","key":"5601_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12967-025-06526-y","volume":"23","author":"Z Hao","year":"2025","unstructured":"Hao Z, Zhang M, Du Y, Liu J, Zeng G, Li H, Peng X (2025) Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies. J Transl Med 23(1):548. https:\/\/doi.org\/10.1186\/s12967-025-06526-y","journal-title":"J Transl Med"},{"issue":"1","key":"5601_CR33","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.gendis.2025.101771","volume":"13","author":"C Liu","year":"2025","unstructured":"Liu C, Wang S, Zhang X, Han Y, Tan M, Fan J, Du J, Fan Y, Zhao X (2025) The biomechanical signature of tumor invasion. Genes Dis 13(1):101771. https:\/\/doi.org\/10.1016\/j.gendis.2025.101771","journal-title":"Genes Dis"},{"issue":"1","key":"5601_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-025-06328-2","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Wang H, Mao D, Che X, Chen Y, Liu Y (2025) Understanding pre-metastatic niche formation: implications for colorectal cancer liver metastasis. J Transl Med 23(1):340. https:\/\/doi.org\/10.1186\/s12967-025-06328-2","journal-title":"J Transl Med"},{"issue":"14","key":"5601_CR35","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.febslet.2012.05.030","volume":"586","author":"J Massagu\u00e9","year":"2012","unstructured":"Massagu\u00e9 J (2012) TGF-\u03b2 signaling in development and disease. FEBS Lett 586(14):1833. https:\/\/doi.org\/10.1016\/j.febslet.2012.05.030","journal-title":"FEBS Lett"},{"issue":"9","key":"5601_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022061","volume":"8","author":"A Hata","year":"2016","unstructured":"Hata A, Chen YG (2016) TGF-\u03b2 signaling from receptors to Smads. Cold Spring Harb Perspect Biol 8(9):a022061. https:\/\/doi.org\/10.1101\/cshperspect.a022061","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5601_CR37","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022145","volume":"9","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Alexander PB, Wang XF (2017) TGF-\u03b2 family signaling in the control of cell proliferation and survival. Cold Spring Harb Perspect Biol 9:a022145. https:\/\/doi.org\/10.1101\/cshperspect.a022145","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"5601_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C et al (2024) TGF-\u03b2 signaling in health, disease, and therapeutics. Signal Transduct Target Ther 9(1):61. https:\/\/doi.org\/10.1038\/s41392-024-01764-w","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5601_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s43556-026-00403-w","volume":"7","author":"J Liu","year":"2026","unstructured":"Liu J, Wang Y, Tang C, Zhang L, Xiong S, Wang J, Dong C (2026) TGF-\u03b2 in tumor development and progression: mechanisms and therapeutics. Mol Biomed 7(1):9. https:\/\/doi.org\/10.1186\/s43556-026-00403-w","journal-title":"Mol Biomed"},{"issue":"1","key":"5601_CR40","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s12967-024-05411-4","volume":"22","author":"AO Giarratana","year":"2024","unstructured":"Giarratana AO, Prendergast CM, Salvatore MM, Capaccione KM (2024) TGF-\u03b2 signaling: critical nexus of fibrogenesis and cancer. J Transl Med 22(1):594. https:\/\/doi.org\/10.1186\/s12967-024-05411-4","journal-title":"J Transl Med"},{"issue":"12","key":"5601_CR41","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1016\/j.bbagen.2014.08.015","volume":"1840","author":"K Mori","year":"2014","unstructured":"Mori K, Ohtani K, Jang S, Kim Y, Hwang I, Roy N, Matsuda Y, Suzuki Y, Wakamiya N (2014) Scavenger receptor CL-P1 mainly utilizes a collagen-like domain to uptake microbes and modified LDL. Biochim Biophys Acta 1840(12):3345\u201356. https:\/\/doi.org\/10.1016\/j.bbagen.2014.08.015","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"5601_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coi.2004.12.001","volume":"17","author":"EP McGreal","year":"2005","unstructured":"McGreal EP, Miller JL, Gordon S (2005) Ligand recognition by antigen-presenting cell C-type lectin receptors. Curr Opin Immunol 17(1):18\u201324. https:\/\/doi.org\/10.1016\/j.coi.2004.12.001","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"5601_CR43","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.13091","volume":"22","author":"H Huang","year":"2021","unstructured":"Huang H, Hu Y, Guo L, Wen Z (2021) Integrated bioinformatics analyses of key genes involved in hepatocellular carcinoma immunosuppression. Oncol Lett 22(6):830. https:\/\/doi.org\/10.3892\/ol.2021.13091","journal-title":"Oncol Lett"},{"issue":"2","key":"5601_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s13402-024-00992-0","volume":"48","author":"M Ryba-Stanis\u0142awowska","year":"2025","unstructured":"Ryba-Stanis\u0142awowska M (2025) Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy. Cell Oncol (Dordr) 48(2):295\u2013312. https:\/\/doi.org\/10.1007\/s13402-024-00992-0","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"5601_CR45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/imr.13176","volume":"314","author":"BB Antuamwine","year":"2023","unstructured":"Antuamwine BB, Bosnjakovic R, Hofmann-Vega F, Wang X, Theodosiou T, Iliopoulos I, Brandau S (2023) N1 versus N2 and PMN-MDSC: A critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology. Immunol Rev 314(1):250\u2013279. https:\/\/doi.org\/10.1111\/imr.13176","journal-title":"Immunol Rev"},{"key":"5601_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3389\/fimmu.2013.00419","volume":"4","author":"B Seliger","year":"2013","unstructured":"Seliger B, Massa C (2013) The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape. Front Immunol 4:419. https:\/\/doi.org\/10.3389\/fimmu.2013.00419","journal-title":"Front Immunol"},{"issue":"5","key":"5601_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051179","volume":"14","author":"G Godoy-Tena","year":"2022","unstructured":"Godoy-Tena G, Ballestar E (2022) Epigenetics of dendritic cells in tumor immunology. Cancers (Basel) 14(5):1179. https:\/\/doi.org\/10.3390\/cancers14051179","journal-title":"Cancers (Basel)"},{"key":"5601_CR48","unstructured":"National Comprehensive Cancer Network (2019) National Comprehensive Cancer Network (NCCN) pancreatic adenocarcinoma (v3.2019)"},{"issue":"10018","key":"5601_CR49","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(15)00986-1","volume":"387","author":"A Wang-Gillam","year":"2016","unstructured":"Wang-Gillam A, Li CP, Bodoky G et al (2016) Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet 387(10018):545\u2013557. https:\/\/doi.org\/10.1016\/S0140-6736(15)00986-1","journal-title":"Lancet"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05601-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05601-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05601-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:14:55Z","timestamp":1787908495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05601-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5601"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05601-2","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (Approval No. 2023-25), The Experimental Animal Management and Use Committee of Chongqing Medical University approved the experiment (Approval number: IACUC-CQMU-2023-04028).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}